Company intelligence / Profile preview

Pavacap

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Pavacap is an early-stage biotechnology company focused on developing innovative drug-delivery solutions for cardiovascular health. The company's primary technology involves a specialized drug-delivery system designed to treat vascular conditions such as atherosclerosis and stenosis by providing localized, controlled release of therapeutic agents. By integrating advanced materials with targeted delivery mechanisms, Pavacap aims to improve the efficacy and safety of interventional cardiology procedures. The company is currently in the pre-clinical phase, refining its lead candidates and delivery platforms.

Therapeutic areas: Cardiovascular
Modalities: DeviceDrug-device combination
Industry: Biotech

Beyond the preview

Go deeper on Pavacap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pavacap.

Explore the full profile